Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation
Authors:
Open Access
- 1 March 2005
- journal article
- research article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 12 (1) , 119-134
Abstract
In a previous report, we showed that increased activation of Akt, a downstream effector of phosphoinositide 3-kinase (PI3K) together with decreased activation of extracellular-signal-regulated kinase (ERK), a member of the mitogen-activated protein kinase (MAPK) family, predicted poor clinical outcome in prostate cancer (Kreisberg et al. 2004 Cancer Research 64 5232–5236). We now show that Akt activation, but not ERK activation, is correlated with proliferation in human prostate tumors as estimated by the expression of the cell proliferation antigen Ki67. We verified these results in vitro, using the androgen-dependent prostate cancer cell line LNCaP and its androgen-independent clone C4-2 as models of prostate cancer of good and poor clinical outcome, respectively. C4-2 cells expressed higher Akt activation, lower ERK activation and increased proliferation compared with LNCaP cells, similar to cases of poor clinical outcome. The PI3K inhibitor LY294002, but not the MAPK/ERK kinase inhibitor PD98059, induced growth arrest in both cell lines. Transient transfection with constitutively active Akt increased proliferation while dominant negative Akt decreased it, thus showing that Akt plays an important role in prostate cancer proliferation. Akt regulates the expression and activation of the androgen receptor. Androgen receptor inhibition with Casodex induced growth arrest in LNCaP cells, but not in C4-2 cells. Another PI3K downstream effector, p70 S6 kinase, requires prior phosphorylation by mammalian target of rapamycin (mTOR) for complete activation. Activation of p70 S6 kinase was higher in C4-2 compared with LNCaP cells. Rapamycin, an mTOR inhibitor, had a growth-inhibitory effect in C4-2 cells, but not in LNCaP cells. Our data suggest a shift from a Casodex-sensitive proliferation pathway in LNCaP cells to a rapamycin-sensitive pathway in C4-2 cells.Keywords
This publication has 53 references indexed in Scilit:
- Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κBBiochemical and Biophysical Research Communications, 2004
- Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancerThe Prostate, 2003
- Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer modelsThe Prostate, 2003
- Androgen receptor - an update of mechanisms of action in prostate cancerUrological Research, 2000
- The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKBExperimental Cell Research, 1999
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- The modular phosphorylation and activation of p70s6kFEBS Letters, 1997
- Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancerThe Prostate, 1996
- Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cellsInternational Journal of Cancer, 1994
- Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994